Document:

Exhibit 10.6

 

PRIVATE PLACEMENT

WARRANTS PURCHASE AGREEMENT

 

THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT,
dated as of         , 2020 (this “Agreement”), is entered into by and
between TWC Tech Holdings II Corp., a Delaware corporation (the “Company”), and TWC Tech Holdings II, LLC, a
Delaware limited liability company (the “Purchaser”).

 

WHEREAS, the Company intends to consummate
an initial public offering of the Company’s units (the “Public Offering”), each unit consisting of one
share of the Company’s Class A common stock, par value $0.0001 per share (a “Share”), and one-third
of one redeemable warrant, each whole warrant exercisable for one Share at an exercise price of $11.50 per Share, as set forth
in the Company’s registration statement on Form S-1 related to the Public Offering (the “Registration Statement”);
and

 

WHEREAS, the Purchaser now wishes to purchase
an aggregate of 8,666,667 warrants (or 9,716,667 warrants if the underwriters’ over-allotment option is exercised in full)
(the “Warrants”), each Warrant entitling the holder to purchase one Share at an exercise price of $11.50 per
Share.

 

NOW THEREFORE, in consideration of the mutual
promises contained in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties to this Agreement hereby, intending legally to be bound, agree as follows:

 

AGREEMENT

 

Section 1. Authorization,
Purchase and Sale; Terms of the Warrants.

 

A. Authorization
of the Warrants. The Company has duly authorized the issuance and sale of the Warrants to the Purchaser.

 

B. Purchase
and Sale of the Warrants.

 

(i) As
payment in full for the 8,666,667 Warrants being purchased under this Agreement, the Purchaser shall pay $13,000,000 (the “Purchase
Price”), by wire transfer of immediately available funds in accordance with the Company’s wiring instructions,
at least one (1) business day prior to the effective date of the Registration Statement, or on such other date as the Company
and the Purchaser may agree.

 

(ii) In
the event that the underwriters’ over-allotment option is exercised in full, the Purchaser shall purchase up to an additional
1,050,000 Warrants (the “Additional Warrants”), in the same proportion as the amount of the over-allotment option
that is exercised, and simultaneously with such purchase of Additional Warrants, as payment in full for the Additional Warrants
being purchased hereunder, and at least one (1) business day prior to the closing of all or any portion of the over-allotment
option, or on such other date as the Company and the Purchaser may agree, the Purchaser shall pay $1.50 per Additional Warrant,
up to an aggregate amount of $1,575,000, by wire transfer of immediately available funds in accordance with the Company’s
wiring instructions.

 

(iii) The
closing of the purchase and sale of the Warrants shall take place simultaneously with the closing of the Public Offering (the “Initial
Closing Date”). The closing of the purchase and sale of the Additional Warrants, if applicable, shall take place simultaneously
with the closing of all or any portion of the over-allotment option (such closing date, together with the Initial Closing Date,
the “Closing Dates” and each, a “Closing Date”). The closing of the purchase and sale of
each of the Warrants and the Additional Warrants shall take place at the offices of Ellenoff Grossman & Schole LLP, 1345 Avenue
of the Americas, New York, New York 10105, or such other place as may be agreed upon by the parties hereto.

 

     

     

    

 

C. Terms
of the Warrants.

 

(i) The
Warrants shall have their terms set forth in a Warrant Agreement to be entered into by the Company and a warrant agent, in connection
with the Public Offering (a “Warrant Agreement”).

 

(ii) At
or prior to the time of the Initial Closing Date, the Company and the Purchaser shall enter into a registration rights agreement
(the “Registration Rights Agreement”) pursuant to which the Company will grant certain registration rights to
the Purchaser relating to the Warrants and the Shares underlying the Warrants.

 

Section 2. Representations
and Warranties of the Company. As a material inducement to the Purchaser to enter into this Agreement and purchase the Warrants,
the Company hereby represents and warrants to the Purchaser (which representations and warranties shall survive the Closing Dates)
that:

 

A. Organization
and Corporate Power. The Company is a corporation duly organized, validly existing and in good standing under the laws of the
State of Delaware and is qualified to do business in every jurisdiction in which the failure to so qualify would reasonably be
expected to have a material adverse effect on the financial condition, operating results or assets of the Company. The Company
possesses all requisite corporate power and authority necessary to carry out the transactions contemplated by this Agreement and
the Warrant Agreement.

 

B. Authorization;
No Breach.

 

(i) The
execution, delivery and performance of this Agreement and the Warrants have been duly authorized by the Company as of the Closing
Dates. This Agreement constitutes a valid and binding obligation of the Company, enforceable in accordance with its terms. Upon
issuance in accordance with, and payment pursuant to, the terms of the Warrant Agreement and this Agreement, the Warrants will
constitute valid and binding obligations of the Company, enforceable in accordance with their terms as of the Closing Dates.

 

(ii) The
execution and delivery by the Company of this Agreement and the Warrants, the issuance and sale of the Warrants, the issuance of
the Shares upon exercise of the Warrants and the fulfillment of, and compliance with, the respective terms hereof and thereof by
the Company, do not and will not as of the Closing Dates (a) conflict with or result in a breach of the terms, conditions
or provisions of, (b) constitute a default under, (c) result in the creation of any lien, security interest, charge or
encumbrance upon the Company’s capital stock or assets under, (d) result in a violation of, or (e) require any
authorization, consent, approval, exemption or other action by or notice or declaration to, or filing with, any court or administrative
or governmental body or agency pursuant to the certificate of incorporation or the bylaws of the Company (in effect on the date
hereof or as may be amended prior to completion of the contemplated Public Offering), or any material law, statute, rule or
regulation to which the Company is subject, or any agreement, order, judgment or decree to which the Company is subject, except
for any filings required after the date hereof under federal or state securities laws.

 

C. Title
to Securities. Upon issuance in accordance with, and payment pursuant to, the terms hereof and the Warrant Agreement, the Shares
issuable upon exercise of the Warrants will be duly and validly issued, fully paid and nonassessable. Upon issuance in accordance
with, and payment pursuant to, the terms hereof and the Warrant Agreement, the Purchaser will have good title to the Warrants and
the Shares issuable upon exercise of such Warrants, free and clear of all liens, claims and encumbrances of any kind, other than
(i) transfer restrictions hereunder and under the other agreements contemplated hereby, (ii) transfer restrictions under
federal and state securities laws, and (iii) liens, claims or encumbrances imposed due to the actions of the Purchaser.

 

D. Governmental
Consents. No permit, consent, approval or authorization of, or declaration to or filing with, any governmental authority is
required in connection with the execution, delivery and performance by the Company of this Agreement or the consummation by the
Company of any other transactions contemplated hereby.

 

    2

     

    

 

E. Regulation
D Qualification. Neither the Company nor, to its knowledge, any of its affiliates, officers, directors or beneficial stockholders
of 20% or more of its outstanding securities, has experienced a disqualifying event as enumerated pursuant to Rule 506(d) of
Regulation D under the Securities Act of 1933, as amended (the “Securities Act”).

 

Section 3.  Representations
and Warranties of the Purchaser. As a material inducement to the Company to enter into this Agreement and issue and sell the
Warrants to the Purchaser, the Purchaser hereby represents and warrants to the Company (which representations and warranties
shall survive the Closing Dates) that:

 

A. Organization
and Requisite Authority. The Purchaser possesses all requisite power and authority necessary to carry out the transactions
contemplated by this Agreement.

 

B. Authorization;
No Breach.

 

(i) This
Agreement constitutes a valid and binding obligation of the Purchaser, enforceable in accordance with its terms, subject to bankruptcy,
insolvency, fraudulent conveyance, reorganization, moratorium and other laws of general applicability relating to or affecting
creditors’ rights and to general equitable principles (whether considered in a proceeding in equity or law).

 

(ii) The
execution and delivery by the Purchaser of this Agreement and the fulfillment of and compliance with the terms hereof by the Purchaser
does not and shall not as of the Closing Dates conflict with or result in a breach by the Purchaser of the terms, conditions or
provisions of any agreement, instrument, order, judgment or decree to which the Purchaser is subject.

 

C. Investment
Representations.

 

(i) The
Purchaser is acquiring the Warrants and, upon exercise of the Warrants, the Shares issuable upon such exercise (collectively, the
“Securities”), for the Purchaser’s own account, for investment purposes only and not with a view towards,
or for resale in connection with, any public sale or distribution thereof.

 

(ii) The
Purchaser is an “accredited investor” as such term is defined in Rule 501(a)(3) of Regulation D under the
Securities Act and the Purchaser has not experienced a disqualifying event as enumerated pursuant to Rule 506(d) of Regulation
D under the Securities Act.

 

(iii) The
Purchaser understands that the Securities are being offered and will be sold to it in reliance on specific exemptions from the
registration requirements of the United States federal and state securities laws and that the Company is relying upon the truth
and accuracy of, and the Purchaser’s compliance with, the representations and warranties of the Purchaser set forth herein
in order to determine the availability of such exemptions and the eligibility of the Purchaser to acquire such Securities.

 

(iv) The
Purchaser did not enter into this Agreement as a result of any general solicitation or general advertising within the meaning of
Rule 502(c) under the Securities Act.

 

(v) The
Purchaser has been furnished with all materials relating to the business, finances and operations of the Company and materials
relating to the offer and sale of the Securities which have been requested by the Purchaser. The Purchaser has been afforded the
opportunity to ask questions of the executive officers and directors of the Company. The Purchaser understands that its investment
in the Securities involves a high degree of risk and it has sought such accounting, legal and tax advice as it has considered necessary
to make an informed investment decision with respect to the acquisition of the Securities.

 

(vi) The
Purchaser understands that no United States federal or state agency or any other government or governmental agency has passed on
or made any recommendation or endorsement of the Securities or the fairness or suitability of the investment in the Securities
by the Purchaser nor have such authorities passed upon or endorsed the merits of the offering of the Securities.

 

    3

     

    

 

(vii) The
Purchaser understands that: (a) the Securities have not been and are not being registered under the Securities Act or any
state securities laws, and may not be offered for sale, sold, assigned or transferred unless (1) subsequently registered thereunder
or (2) sold in reliance on an exemption therefrom; and (b) except as specifically set forth in the Registration Rights
Agreement, neither the Company nor any other person is under any obligation to register the Securities under the Securities Act
or any state securities laws or to comply with the terms and conditions of any exemption thereunder.

 

(viii) The
Purchaser has such knowledge and experience in financial and business matters, knowledge of the high degree of risk associated
with investments in the securities of companies in the development stage such as the Company, is capable of evaluating the merits
and risks of an investment in the Securities and is able to bear the economic risk of an investment in the Securities in the amount
contemplated hereunder for an indefinite period of time. The Purchaser has adequate means of providing for its current financial
needs and contingencies and will have no current or anticipated future needs for liquidity which would be jeopardized by the investment
in the Securities. The Purchaser can afford a complete loss of its investments in the Securities.

 

Section 4. Conditions
of the Purchaser’s Obligations. The obligations of the Purchaser to purchase and pay for the Warrants are subject to
the fulfillment, on or before the Closing Dates, of each of the following conditions:

 

A. Representations
and Warranties. The representations and warranties of the Company contained in Section 2 shall be true
and correct at and as of the Closing Dates as though then made.

 

B. Performance.
The Company shall have performed and complied with all agreements, obligations and conditions contained in this Agreement that
are required to be performed or complied with by it on or before the Closing Dates.

 

C. No
Injunction. No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted,
entered, promulgated or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory
organization having authority over the matters contemplated hereby, which prohibits the consummation of any of the transactions
contemplated by this Agreement or the Warrant Agreement.

 

D. Warrant
Agreement. The Company shall have entered into a Warrant Agreement with a warrant agent on terms satisfactory to the Purchaser
(the “Warrant Agreement”).

 

Section 5. Conditions
of the Company’s Obligations. The obligations of the Company to the Purchaser under this Agreement are subject to the
fulfillment, on or before the Closing Dates, of each of the following conditions:

 

A. Representations
and Warranties. The representations and warranties of the Purchaser contained in Section 3 shall be true
and correct at and as of the Closing Dates as though then made.

 

B. Performance.
The Purchaser shall have performed and complied with all agreements, obligations and conditions contained in this Agreement that
are required to be performed or complied with by the Purchaser on or before the Closing Dates.

 

C. No
Injunction. No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted,
entered, promulgated or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory
organization having authority over the matters contemplated hereby, which prohibits the consummation of any of the transactions
contemplated by this Agreement or the Warrant Agreement.

 

    4

     

    

 

D. Warrant
Agreement. The Company shall have entered into the Warrant Agreement.

 

Section 6. Termination.
This Agreement may be terminated at any time after December 31, 2020 upon the election by either the Company or a Purchaser entitled
to purchase a majority of the Warrants upon written notice to the other parties if the closing of the Public Offering does not
occur prior to such date.

 

Section 7. Survival
of Representations and Warranties. All of the representations and warranties contained herein shall survive the Closing Dates.

 

Section 8. Definitions.
Terms used but not otherwise defined in this Agreement shall have the meaning assigned to such terms in the Registration Statement.

 

Section 9.
Miscellaneous.

 

A. Successors
and Assigns. Except as otherwise expressly provided herein, all covenants and agreements contained in this Agreement by or
on behalf of any of the parties hereto shall bind and inure to the benefit of the respective successors of the parties hereto whether
so expressed or not. Notwithstanding the foregoing or anything to the contrary herein, the parties may not assign this Agreement,
other than assignments by the Purchaser to affiliates thereof.

 

B. Severability.
Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable law, such provision shall be
ineffective only to the extent of such prohibition or invalidity, without invalidating the remainder of this Agreement.

 

C. Counterparts.
This Agreement may be executed simultaneously in two or more counterparts, none of which need contain the signatures of more than
one party, but all such counterparts taken together shall constitute one and the same agreement.

 

D. Descriptive
Headings; Interpretation. The descriptive headings of this Agreement are inserted for convenience only and do not constitute
a substantive part of this Agreement. The use of the word “including” in this Agreement shall be by way of example
rather than by limitation.

 

E. Governing
Law. This Agreement and the rights and obligations of the parties hereunder shall be construed in accordance with and governed
by the laws of New York applicable to contracts wholly performed within the borders of such state, without giving effect to the
conflict of law principles thereof. The parties hereto irrevocably submit to the exclusive jurisdiction of any federal court sitting
in the Southern District of New York or any state court located in New York County, State of New York, over any suit, action or
proceeding arising out of or relating to this Agreement. To the fullest extent they may effectively do so under applicable law,
the parties hereto irrevocably waive and agree not to assert, by way of motion, as a defense or otherwise, any claim that they
are not subject to the jurisdiction of any such court, any objection that they may now or hereafter have to the laying of the venue
of any such suit, action or proceeding brought in any such court and any claim that any such suit, action or proceeding brought
in any such court has been brought in an inconvenient forum.

 

F. Amendments.
This letter agreement may not be amended, modified or waived as to any particular provision, except by a written instrument executed
by all parties hereto.

 

[Signature page follows]

 

    5

     

    

 

IN WITNESS WHEREOF, the parties hereto
have executed this Agreement to be effective as of the date first set forth above.

 

	 	COMPANY:
	 	 
	 	TWC TECH HOLDINGS II CORP.

 

	 	By:	 
	 	 	Name:
	 	 	Title:

 

	 	TWC TECH HOLDINGS II, LLC

 

	 	By:	 
	 	 	Name:
	 	 	Title:

 

[Signature Page to Private Placement
Warrants Purchase Agreement]EX-10.1

 Exhibit 10.1 

August 29, 2020 
 Keith
Bethel 
 Dear Keith: 
 This Letter Agreement
and General Release (this “Letter Agreement”) will confirm our agreement regarding your retirement from service with Aramark. For purposes of this Letter Agreement, “Aramark” shall include Aramark, Aramark Services, Inc., and
each of their affiliates, subsidiaries, divisions, lines of business and any corporation, joint venture, or other entity in which Aramark or its subsidiaries have an equity interest in excess of ten percent (10%). 

We have agreed as follows: 

1.    Retirement from Employment: 

(a)    Effective as of August 30, 2020 at 5:00 p.m. (the “Transition Date”), you will cease to serve as an
Executive Officer of Aramark, Chief Growth Officer of Aramark, and all other formal officer positions you may hold within Aramark. Beginning on the Transition Date and ending on December 1, 2020, Aramark hereby appoints you to serve in the role
of Executive Advisor. In such role, subject to your execution of this Letter Agreement and the Release and Waiver of Claims attached as Appendix A to this Letter Agreement (the “First Release”) on or before August 30 at 5:00 p.m., you
will remain a full-time employee of Aramark between the Transition Date and December 1, 2020 (the “Separation Date”) for purposes of Aramark’s employment policies, plans and practices and will continue to receive payments of your
annual base salary in accordance with Aramark’s regular payroll. The payment of your annual base salary during the time period between the Transition Date and the Separation Date (the “Advisory Period”) will reflect the twenty-five
percent (25%) reduction in base salary currently in effect for all members of the Executive Leadership Team, unless and until the twenty-five percent (25%) reduction in base salary is eliminated for all members of the Executive Leadership Team.
During the Advisory Period, you will provide such services as the Chief Executive Officer of Aramark shall reasonably request, including assisting with the transition of your duties. At all times on and after the Transition Date, you shall not act
for, bind or represent Aramark for any purpose, except as may be reasonably requested by the CEO. During the Advisory Period, you will provide services to Aramark on an exclusive basis and shall not provide services to any other entity. 

(b)    Your retirement from employment with Aramark will be effective upon the Separation Date, unless you are terminated
earlier for Cause as defined in Article 6.B of the Amended and Restated Aramark Agreement Relating to Employment and Post-Employment Competition between you and Aramark dated July 16, 2020 (the “Post-Employment Competition Agreement”)
or resign earlier for any reason. If you do not sign this Letter Agreement and the First Release on or before August 30, 2020 at 5:00 p.m., or if, prior to the Separation Date, Aramark terminates your employment for Cause or you resign for any
reason, the terms and conditions of your separation from service will be governed by the Post-Employment Competition Agreement, and this Letter Agreement will be null and void ab initio. 

 2.    Separation Payments: In consideration
for your obligations under this Letter Agreement, including but not limited to your execution without revocation of the Release and Waiver of Claims attached as Appendix B to this Letter Agreement (the “Second Release”) on or after
December 1, 2020, but no later than December 8, 2020, and subject to the other provisions of this Letter Agreement, you shall receive the following payments (collectively, the “Separation Payments”): 

(a)    For a period of eighteen (18) months, payments of $41,666.67 (i.e., 1/12th of your annual salary prior to the twenty-five percent (25%) reduction in base salary currently in place for all members of the Executive Leadership Team) per month (the “Salary Continuation
Payments”). Salary Continuation Payments shall be paid in accordance with Aramark’s normal payroll cycle, less all applicable withholding taxes and payroll deductions, and shall commence within sixty (60) days following the Separation
Date. The period during which you are eligible to receive your Salary Continuation Payments (the “Separation Pay Period”) shall commence with the Separation Date, assuming that you timely execute this Letter Agreement, the First Release
and the Second Release, and do not revoke the Second Release, in accordance with each of the terms hereof and thereof. 

(b)    A pro rata bonus under the Management Incentive Plan, as defined in Paragraph 3 below, in respect of Aramark fiscal
year 2021, as set forth in Article 6.A, Section 1(b) of the Post-Employment Competition Agreement. For the avoidance of doubt, any pro rata bonus in respect of Aramark fiscal year 2021 will be based on actual achievement of the applicable
Financial Objective metrics for fiscal year 2021 and actual achievement of the applicable Individual Objective metrics for fiscal year 2021, calculated in the same way that such bonuses are calculated for all members of the Executive Leadership Team
for that fiscal year. Your pro rata bonus in respect of Aramark fiscal year 2021 will be paid, minus all applicable withholdings, at the same time annual bonuses for fiscal year 2021 are paid under the Management Incentive Plan, but in no event
later than March 15, 2022. 
 (c)    In satisfaction of the payments owed to you under Article 6.A,
Section 1(c) of the Post-Employment Competition Agreement, the following payments in the aggregate amount of $637,500 (i.e., one and one-half times the target amount payable to you under the Management
Incentive Plan, as defined in Paragraph 3 below, in respect of Aramark’s fiscal year ending October 2, 2020): 

(i)    On December 29, 2020, a payment of $350,433.56, less all applicable withholding taxes and payroll deductions;
and 
 (ii)    Payments paid in accordance with Aramark’s normal payroll cycle as follows, less all applicable
withholding taxes and payroll deductions: 
  

							
		  	Monthly Payment Period	  	Amount	  	
		  	October 2021	  	$3,733.11	  	
		  	November 2021	  	$35,416.67	  	
		  	December 2021	  	$35,416.67	  	
		  	January 2022	  	$35,416.67	  	
		  	February 2022	  	$35,416.67	  	
		  	March 2022	  	$35,416.67	  	
		  	April 2022	  	$35,416.66	  	
		  	May 2022	  	$35,416.66	  	
		  	June 2022	  	$35,416.66	  	

  
 2 

 These payments described in clauses (a), (b) and (c) above shall constitute full
satisfaction of any obligations owed to you by Aramark under Article 6.A, Section 1 of the Post-Employment Competition Agreement. 

3.    Bonus Payments: Pursuant to the terms of the Amended and Restated Management Incentive
Bonus Plan (the “Management Incentive Plan”), if your employment ends on the Separation Date, you will have been an employee of Aramark on the last day of fiscal year 2020, and thus will be eligible to receive a bonus under the Management
Incentive Plan for such fiscal year. If, prior to the Separation Date, Aramark terminates your employment for Cause or, prior to October 2, 2020, you resign for any reason, you will not be eligible for and will not receive a Management
Incentive Bonus for fiscal year 2020. To the extent you are eligible, you will receive a payment of your fiscal year 2020 annual bonus, minus all applicable withholdings, at the same time annual bonuses are typically paid under the Management
Incentive Plan (and in no event later than March 15, 2021). For the avoidance of doubt, your fiscal year 2020 annual bonus will be based on actual achievement of the applicable Financial Objective metrics for fiscal year 2020 and actual
achievement of the applicable Individual Objective metrics for fiscal year 2020, calculated in the same way that such bonuses are calculated for all other members of the Executive Leadership Team for that fiscal year. Because you will not be
employed on the last day of Aramark fiscal year 2021, you will not be eligible for and will not receive a bonus under the terms of the Management Incentive Plan for fiscal year 2021 or otherwise, except as set forth in paragraph 2(b) above. 

4.    Group Insurance; Vacation; Auto Allowance; Reimbursement of Expenses; Career Continuation Services:

 (a)    If you execute this Letter Agreement, the First Release and the Second Release and do not revoke the Second
Release, then in full satisfaction of any obligations owed to you by Aramark under Article 6, Section A.2(a) of the Post-Employment Competition Agreement, you will continue to be eligible to receive group medical and life insurance coverages during
the Separation Pay Period under Aramark’s plans in which you were participating immediately prior to your Separation Date in accordance with your benefits elections, subject to the terms of the applicable plan documents and to such changes to
the terms of such plans as Aramark determines to apply to its employees (the period of time during which you receive the relevant coverages from Aramark shall be referred to hereinafter as the “Benefits Continuation Period”). 

During the Benefits Continuation Period, the cost of your group medical and life insurance coverages shall continue to be subsidized by Aramark and your share
of the premiums will be deducted from your Separation Payments. 
 Your rights under COBRA to continue your group medical insurance coverages beyond the
Benefits Continuation Period are at your expense. Please note that your rights under COBRA commence with the Separation Date and run concurrently with the Benefits Continuation Period. You must elect COBRA coverage in accordance with the information
that will be sent to you. Note that due to your separation from service, you have the option to elect coverage under the Public Health Exchange as an alternative to COBRA. If you elect coverage, you will not be eligible to enroll for coverage on the
Public Health Exchange until you have exhausted your COBRA coverage, until the next Public Health Exchange open enrollment period or if you qualify for a Public Health Exchange special enrollment opportunity. 

  
 3 

 If you become employed by a new employer at any time during the Separation Pay Period, continued coverages
under this Paragraph 4 shall become secondary to any such coverages provided to you by the new employer. 
 In addition, you may have the ability to convert
certain non-health insurance coverages to individual policies. Further information regarding coverage continuation and conversion may be obtained from Todd Lombardi. Notwithstanding the foregoing, Aramark
reserves the right to restructure the provision of continued medical coverage in any manner necessary or appropriate to avoid fines, penalties or negative tax consequences to Aramark or you (including, without limitation, to avoid any penalty
imposed for violation of the nondiscrimination requirements under the Patient Protection and Affordable Care Act or the guidance issued thereunder), as determined by Aramark in its sole and absolute discretion. 

(b)    In full satisfaction of any obligations owed to you by Aramark under Article 6, Section A.2(b) of the
Post-Employment Competition Agreement, you will continue to receive your monthly company car allowance of $1,100 per month through the Separation Pay Period, provided that to receive such allowance, you must execute this Letter Agreement, the First
Release and the Second Release and must not revoke the Second Release. This allowance is subject to all applicable withholding taxes. 

(c)    In further consideration of your obligations under this Letter Agreement, Aramark will reimburse you for all
reasonable expenses you incur for professional outplacement services provided during the Separation Pay Period by qualified consultants employed by a recognized outplacement services firm you select, in an amount not to exceed 10% of your base
salary as of the Separation Date, provided that to receive these services, you must execute this Letter Agreement, the First Release and the Second Release and must not revoke the Second Release. You will not receive any payment pursuant to this
paragraph except in reimbursement for professional outplacement services that are actually performed on your behalf during the Separation Pay Period. All such reimbursement payments will be made prior to December 31, 2022. 

(d)    You will be reimbursed, in accordance with normal Aramark policy, for any business expenses you incurred on or
before the Transition Date and which are submitted to Aramark for reimbursement on or before September 30, 2020 and any expense pre-approved by Aramark during the Advisory Period for which a
request for reimbursement is submitted to Aramark on or before December 15, 2020. 
 (e)    You will accrue
vacation days during the Advisory Period in accordance with Aramark’s policies and procedures as in effect from time to time. You will receive payment for any earned, accrued and unused vacation through the Separation Date by not later than the
second payroll period following your Separation Date. 
 5.    No Other Amounts Due: You
acknowledge that Aramark has paid you all wages, salaries, bonuses, benefits, and other amounts earned and accrued, less applicable deductions, and that Aramark has no obligation to pay any additional amounts other than the payments and benefits
described in this Letter Agreement. 
 6.    Other Executive Benefits and Perquisites: Your
membership in the Executive Leadership Council and Executive Leadership Team shall terminate as of the Separation Date. All Executive Leadership Council benefits including, but not limited to, your Executive Health

  
 4 

 
Plan, Executive Physical Program and Executive Supplemental Long-Term Disability shall continue to be provided to you until the Separation Date and shall terminate, unless otherwise provided
under the applicable plan or program, as of the Separation Date (except that your Executive Health Plan benefits shall terminate on the last day of the calendar month in which your Separation Date falls). Consistent with the provision of benefits as
described in Paragraph 4 above, you do have certain rights under COBRA to elect to continue your Executive Health Plan coverage at your expense. You shall receive additional information regarding your option to continue this coverage. Further
information regarding coverage continuation and conversion may be obtained from Todd Lombardi. 

7.    Aramark Separation Plans: You have accounts under the Aramark Savings Incentive
Retirement Plan (the “SIRP”) and the Aramark 401(k) Plan. Your active participation under the SIRP will terminate as of the Separation Date. Under the terms of the SIRP, you will not be eligible to make further salary deferrals following
the Separation Date, but you will receive the company contribution for plan year 2020 if you remain employed until the Separation Date. You will not receive any company contributions beyond plan year 2020. Processing of your SIRP account for
distribution will begin after the Separation Date in accordance with the terms of the SIRP, including the terms related to compliance with Section 409A (as defined in paragraph 15 below). You may obtain further details on SIRP distributions
from Todd Lombardi. For options available under the Aramark 401(k) Plan, contact Fidelity Investments at 1-877-236-9472. 

8.    Equity/Stock Plans: 

(a)    Equity-Based Awards: The effect the separation of your service with Aramark will have on
your rights, if any, with respect to any outstanding Aramark stock options or other equity-based awards that you may hold immediately prior to the Separation Date (collectively, the “Equity Awards”) will be as set forth in the terms of the
Post-Employment Competition Agreement and the applicable Aramark incentive plan and award documents or agreements. Your Equity Award records will be updated by Fidelity, Aramark’s equity program administrator, as soon as administratively
possible following the Separation Date and its website will display the remaining vested Equity Awards with each award’s revised expiration date (i.e., for stock options, 90 days from the Separation Date). You may view your Equity Award records
on Fidelity’s website at https://nb.fidelity.com/public/nb/default/home or contact a Customer Service Representative at Fidelity at
1-800-544-9354. You may receive separate correspondence from Fidelity regarding these awards, but in the meantime, you can obtain
further details as to the effect your separation from service will have on such awards from Todd Lombardi. Prior to the Separation Date, your equity-based awards, including your Performance Stock Units, Restricted Stock Units, and Non-Qualified Stock Options, will receive the same vesting treatment as the equivalent equity-based awards held by all other members of the Executive Leadership Team. 

(b)    Stock of Aramark: The records for the Aramark common stock that you own, if applicable,
will continue to be kept by Aramark’s current transfer agent, Fidelity or, if applicable, its former transfer agent, Computershare, or their successors, until you sell the stock or transfer it to a broker. If your stock is pledged as collateral
or otherwise restricted on the transfer agent’s records, your stock will remain restricted and unavailable for sale or transfer pending resolution of the underlying restriction. You can view your holdings on Fidelity’s or
Computershare’s websites. 

  
 5 

 9.    Withholding: You are solely
responsible for the payment of any and all taxes that result from the payments and benefits due to you under this Letter Agreement. Aramark may, to the extent permitted by law, withhold applicable federal, state and local income and other taxes from
any payments due to you hereunder. 
 10.    Return of Aramark Property: On or before the
Separation Date, you shall return to Aramark all documents, manuals, computers, computer programs, discs, drives, customer lists, notebooks, reports and other written or graphic materials, including all copies thereof, relating in any way to
Aramark’s business and prepared by you or obtained by you from Aramark, its affiliates, clients or its suppliers during the course of your employment with Aramark. Further, to the extent that you made use of your own personal computing devices
(e.g., PDA, smart phone, laptop, thumb drive, etc.) during your employment with Aramark, subject to any applicable litigation hold directive that you received and that remains in effect, you agree to provide such devices to Aramark in order for
Aramark to either permanently delete all Aramark property and information from such personal computing devices or replace same (which replacement shall include any personal information as contained on such devices). 

11.    Post-Employment Restrictions; Entire Agreement: This Letter Agreement and its
Appendices A and B, and any restrictive, clawback or other applicable covenants that apply on and following any separation from service under any Equity Awards, as applicable, constitute the entire agreement between the parties on the subject of
payments and benefits due to you upon your separation from service with Aramark and post-employment payments and benefits; and, except as expressly provided herein, supersede all other prior agreements concerning the terms of any and all payments
and benefits to which you may be entitled upon your separation from service, including the Post-Employment Competition Agreement, except that the provisions of Articles 1 (Non-Disclosure and Non-Disparagement), 2 (Non-Competition), 3 (Non-Solicitation), 4 (Discoveries and Works), 5 (Remedies), 6.E (Post-Employment Benefits),
8.A, B, I, and J (Miscellaneous) of the Post-Employment Competition Agreement, shall continue to apply and are hereby made a part of this Letter Agreement by reference. Notwithstanding any provision in this Letter Agreement to the contrary, all
payments hereunder are expressly made contingent on your compliance in all respects with all of the terms and conditions of the above-referenced provisions of Articles 1, 2, 3 and 4 of the Post-Employment Competition Agreement. To the extent that
you breach any of the restrictive covenants set forth in Articles 1, 2, 3 or 4 from the Post-Employment Competition Agreement incorporated by reference in this Paragraph 11, Aramark will, in accordance with the terms of Paragraph 6.D of the
Post-Employment Competition Agreement, have the right to cease payment of any unpaid Separation Payments and post-employment benefits, and otherwise will continue to have the clawback rights under the Equity Awards. 

12.    Remedies: You acknowledge and agree that Aramark may seek injunctive relief in any
court of competent jurisdiction for your failure to comply fully with any of the covenants referenced in Paragraph 11 and any other remedies as may be specified in the Post-Employment Competition Agreement and Equity Awards, as applicable, in
addition to any other legal and monetary remedies which may be available to Aramark. 
 13.    Agreement
and Obligation to Cooperate: In exchange for the benefits provided to you by Aramark under this Letter Agreement, you agree to cooperate fully with Aramark in any investigation instituted by Aramark or any other person or entity into
any Aramark business involving the time period during which you were employed by Aramark. This duty to cooperate will include, but not be limited to, meeting with representatives of Aramark at times and places reasonably designated by Aramark, and
shall continue beyond the Separation Pay Period. 

  
 6 

 14.    Certification of Compliance with Business Conduct
Policy and Laws: By signing this Letter Agreement, you are certifying that you have not violated Aramark’s Business Conduct Policy and that you are not aware of any violation of Aramark’s Business Conduct Policy or of any
law by any other current or former employee of Aramark, involving conduct which occurred during the time period in which you were employed by Aramark. 

15.    Section 409A of the Internal Revenue Code: This Letter Agreement is intended to comply
with Section 409A of the Internal Revenue Code of 1986, as amended, and its corresponding regulations (“Section 409A”), or an exemption thereto, and shall in all respects be administered in accordance with Section 409A, if
applicable. For purposes of Section 409A, payments may only be made under this Letter Agreement upon an event and in a manner permitted by Section 409A, including the requirement that nonqualified deferred compensation subject to
Section 409A cannot be paid to a “specified employee” as that term is defined under Section 409A until a date that is six months following a “separation from service” within the meaning of such term under
Section 409A. For purposes of Section 409A, all payments to be made upon a retirement under this Letter Agreement may only be made upon a “separation from service,” each payment made under this Letter Agreement shall be treated
as a separate payment and the right to a series of installment payments under this Letter Agreement is to be treated as a right to a series of separate payments. In no event shall you, directly or indirectly, designate the calendar year of payment
of any severance benefits that are subject to Section 409A. Any amounts paid hereunder that are subject to Section 409A and that could be paid in more than one taxable year based on the date that you sign this Letter Agreement, the First
Release and the Second Release, will be paid in the second taxable year. All reimbursements and in-kind benefits provided under this Letter Agreement shall be made or provided in accordance with the
requirements of Section 409A. 
 16.    No Offset: If you do become employed or engaged
elsewhere, the payments and benefits set forth in this Letter Agreement shall continue and shall not be offset or reduced by any compensation or benefits you may receive from such other source, subject only to the requirements of the Post-Employment
Competition Agreement provisions incorporated herein and the group medical and life insurance benefits set forth in Paragraph 4 above. 

17.    Severability: In the event that any portion of this Letter Agreement (including
Appendix A or Appendix B) is held to be invalid, unlawful, or unenforceable for any reason, the invalid, unlawful, or unenforceable portion shall be construed or modified in a manner that gives force and effect to the First Release, Second Release
and the remainder of this Agreement to the fullest extent possible. If the invalid, unlawful or unenforceable portion cannot be construed or modified to render it valid, lawful, and enforceable, that portion shall be construed as narrowly as
possible and shall be severed from the remainder of this Agreement, and the remainder of this Agreement shall remain in effect and be construed as broadly as possible, as if the invalid, unlawful, or unenforceable portion had never been contained in
this Agreement. 
 18.    Applicable Law: This Letter Agreement shall be governed by and
construed in accordance with the laws of the Commonwealth of Pennsylvania, without regard to conflicts of laws principles thereof. 

19.    Amendment: This Letter Agreement may only be amended or modified by a written agreement
executed by you and Aramark (or any successor). 

  
 7 

 20.    Counterparts: This Letter Agreement
may be executed in one or more counterparts, which shall, collectively or separately, constitute one agreement. 

21.    Advice of Counsel: Aramark is advising you to have legal counsel, at your expense,
review this Letter Agreement and in particular the First Release and Second Release before you sign this Letter Agreement. 

22.    Non-Disparagement: Aramark, each member of
Aramark’s Board of Directors, and each of the executive officers and members of the Executive Leadership Team of Aramark shall refrain from making any statements or comments of a defamatory or disparaging nature to any third party about you,
other than to comply with law. In accordance with the Post Employment Competition Agreement, you shall refrain from making any statements or comments of a defamatory or disparaging nature to any third party regarding Aramark, or any of
Aramark’s officers, directors, personnel, other service providers, policies or products or services, other than to comply with law. 

Please sign the enclosed copy of this Letter Agreement to signify your understanding and acceptance of the terms and conditions contained
herein and return one original to me by portable document format (.pdf) or facsimile on or before August 30, 2020 at 5:00 p.m. 
  

			
	Very truly yours,
		
	By:	 	 /s/ Lynn B. McKee

		 	Lynn B. McKee

 Enclosures 

The foregoing has been read and accepted as a binding agreement between Aramark and the undersigned this 30th day of August, 2020. 

 

			
	      	 	 /s/ Keith Bethel

		 	Keith Bethel

  
 8 

 APPENDIX A 

First Release and Waiver of Claims 

1.    In consideration for the payments provided for under the Letter Agreement between me, Keith Bethel, and Aramark
dated August 29, 2020 (the “Letter Agreement”) and the Amended and Restated Aramark Agreement Relating to Employment and Post-Employment Competition between me, Keith Bethel, and Aramark Corporation dated July 16, 2020
(“Post-Employment Competition Agreement”), and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, I hereby agree on behalf of myself, my spouse, agents, assignees, attorneys, successors,
assigns, heirs and executors, to fully and completely release Aramark (which term shall be deemed to include Aramark Corporation, Aramark Services, Inc., and all subsidiary and affiliated and successor companies or other entities in which Aramark or
Aramark Services, Inc., or their subsidiaries or affiliates has or had an equity interest in excess of ten percent (10%)), and their predecessors and successors and all of their respective past and/or present officers, directors, partners, members,
managing members, managers, employees, agents, representatives, administrators, attorneys, insurers, shareholders, bondholders, clients, customers, suppliers, distributors, subcontractors, joint-venture partners, consultants and fiduciaries in their
individual and/or representative capacities (hereinafter collectively referred to as the “Aramark Releasees”), to the fullest extent permitted by law, from any and all causes of action and claims whatsoever, which I or my heirs, executors,
administrators, successors and assigns ever had or now have against the Aramark Releasees or any of them, in law, admiralty or equity, whether known or unknown to me, for, upon, or by reason of, any matter, action, omission, course or thing in
connection with or in relationship to: (a) my employment or other service relationship with Aramark; (b) the termination of any such employment or service relationship; (c) any applicable employment, benefit, compensatory or equity
arrangement with Aramark occurring or existing up to the Separation Date; and (d) any equity or stock plans of Aramark (such released claims are collectively referred to herein as the “Released Claims”). 

2.    The Released Claims include, without limitation of the language of paragraph 1, (i) any and all claims under Title
VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Employee Retirement Income Security Act of 1974, the Americans with Disabilities Act, the Family and Medical Leave Act of 1993, the Worker Adjustment Retraining and Notification
Act, the Pennsylvania Human Relations Act (including any claims threatened or pending before the Pennsylvania Human Relations Commission), the Pennsylvania Whistleblower Law and any and all other federal, state or local laws, statutes, rules and
regulations pertaining to employment; and (ii) any claims for wrongful discharge, breach of express or implied contract, fraud, misrepresentation or any claims relating to benefits, compensation or equity, or any other claims under any statute,
rule or regulation or under the common law, including compensatory damages, punitive damages, attorney’s fees, costs, expenses and all claims for any other type of damage or relief. 

3.    The Released Claims shall not include: (i) any vested benefits which I hold under any Aramark pension or
welfare benefit plan; (ii) any claims to enforce my contractual rights under, or with respect to, the Letter Agreement; (iii) any rights to workers’ compensation benefits or unemployment insurance as required by applicable law, or
(iv) any claims that arise after the date on which I execute this First Release and Waiver of Claims. The Release and Waiver of Claims does not apply to claims under the Age Discrimination in Employment Act or any claim that cannot be released
in this Agreement as a matter of law. In addition, nothing 

 
herein prevents me from filing a charge or complaint with the Equal Employment Opportunity Commission (“EEOC”) or similar state or local agency or my ability to participate in any
investigation or proceeding conducted by the EEOC or such similar state or local agency; provided however, that pursuant to Paragraphs 1 and 2 of this First Release and Waiver of Claims, I am waiving, to the fullest extent permitted by law, any
right to recover monetary damages or any other form of personal relief in connection with any such charge, investigation or proceeding. To the extent I receive any personal or monetary relief in connection with any such charge, investigation or
proceeding, Aramark will be entitled to an offset for the payments made pursuant to Paragraph 2 of the foregoing letter agreement. 
 Nothing in the Letter
Agreement or this First Release and Waiver of Claims shall prohibit or restrict me or my attorneys from lawfully, and without notice to Aramark: (a) initiating communications directly with, cooperating with, providing information to, causing
information to be provided to, or otherwise assisting in an investigation by any governmental or regulatory agency, entity, or official(s) (collectively, “Governmental Authorities”) regarding a possible violation of any law;
(b) responding to any inquiry or legal process directed to me individually (and not directed to Aramark and/or its subsidiaries) from any such Governmental Authorities; (b) testifying, participating or otherwise assisting in an action or
proceeding by any such Governmental Authorities relating to a possible violation of law; or (d) making any other disclosures that are protected under the whistleblower provisions of any applicable law. Additionally, pursuant to the federal
Defend Trade Secrets Act of 2016, I shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that: (a) is made (i) in confidence to a federal, state, or local
government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (b) is made to my attorney in relation to a lawsuit for retaliation
against me for reporting a suspected violation of law; or (c) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. Nor does the Letter Agreement or this First Release and
Waiver of Claims require me to obtain prior authorization from Aramark before engaging in any conduct described in this Paragraph, or to notify Aramark that I have engaged in any such conduct. 

4.    I expressly understand and agree that the obligations of Aramark as set forth in the Letter Agreement are in lieu of
any and all other amounts which I might be, am now, or may become, entitled to receive from Aramark upon any claim released herein. I also expressly understand and agree that the Separation Payments paid to me under the Letter Agreement are in
addition to what I would otherwise be entitled to receive following the end of my employment. Other than as provided in the Letter Agreement, I acknowledge and agree that I have received all entitlements due from Aramark relating to my employment
with Aramark including, but not limited to, all wages earned, bonuses, sick pay, vacation pay and any other paid and unpaid leave for which I was eligible and to which I was entitled, and that no other entitlements are due to me other than as set
forth in the Letter Agreement. 
 5.    I acknowledge that my release and waiver of claims is knowing and voluntary and
I acknowledge and agree as follows: 
  

	 	a.	 I have read carefully and fully understand the terms of this First Release and Waiver of Claims and that
Aramark advises me by the Letter Agreement to consult with an attorney and further I have had the opportunity to consult with an attorney prior to signing this First Release and Waiver of Claims. 

  
 2 

	 	b.	 I fully understand the Release and Waiver of Claims that I am signing. 

 

	 	c.	 I am signing this First Release and Waiver of Claims voluntarily and knowingly and I have not relied on any
representations, promises or agreements of any kind made to me in connection with my decision to accept the terms of this First Release and Waiver of Claims, other than those set forth in this First Release and Waiver of Claims and the Letter
Agreement. 

  

	 	d.	 I have been given a reasonable period of time to consider whether I want to sign this First Release and Waiver
of claims. To the extent I have executed this First Release and Waiver of claims prior to the expiration of the period of time I was given to consider it, my decision to do so was entirely voluntary. 

This First Release and Waiver of Claims shall take effect immediately upon execution. 

Intending to be legally bound, I hereby execute this First Release and Waiver of Claims. 

 

	
	 /s/ Keith Bethel

	 Keith Bethel

 DATED: August 30, 2020 

  
 3 

 APPENDIX B 

Second Release and Waiver of Claims 

1.    In consideration for the payments provided for under the Letter Agreement between me, Keith Bethel, and Aramark
dated August 29, 2020 (the “Letter Agreement”) and the Amended and Restated Aramark Agreement Relating to Employment and Post-Employment Competition between me, Keith Bethel, and Aramark Corporation dated July 16, 2020
(“Post-Employment Competition Agreement”), and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, I hereby agree on behalf of myself, my spouse, agents, assignees, attorneys, successors,
assigns, heirs and executors, to fully and completely release Aramark (which term shall be deemed to include Aramark Corporation, Aramark Services, Inc., and all subsidiary and affiliated and successor companies or other entities in which Aramark or
Aramark Services, Inc., or their subsidiaries or affiliates has or had an equity interest in excess of ten percent (10%)), and their predecessors and successors and all of their respective past and/or present officers, directors, partners, members,
managing members, managers, employees, agents, representatives, administrators, attorneys, insurers, shareholders, bondholders, clients, customers, suppliers, distributors, subcontractors, joint-venture partners, consultants and fiduciaries in their
individual and/or representative capacities (hereinafter collectively referred to as the “Aramark Releasees”), to the fullest extent permitted by law, from any and all causes of action and claims whatsoever, which I or my heirs, executors,
administrators, successors and assigns ever had or now have against the Aramark Releasees or any of them, in law, admiralty or equity, whether known or unknown to me, for, upon, or by reason of, any matter, action, omission, course or thing in
connection with or in relationship to: (a) my employment or other service relationship with Aramark; (b) the termination of any such employment or service relationship; (c) any applicable employment, benefit, compensatory or equity
arrangement with Aramark occurring or existing up to the Separation Date; and (d) any equity or stock plans of Aramark (such released claims are collectively referred to herein as the “Released Claims”). 

2.    The Released Claims include, without limitation of the language of paragraph 1, (i) any and all claims under Title
VII of the Civil Rights Act of 1964, the Age Discrimination in Employment Act of 1967, the Civil Rights Act of 1991, the Employee Retirement Income Security Act of 1974, the Americans with Disabilities Act, the Family and Medical Leave Act of 1993,
the Worker Adjustment Retraining and Notification Act, the Pennsylvania Human Relations Act (including any claims threatened or pending before the Pennsylvania Human Relations Commission), the Pennsylvania Whistleblower Law and any and all other
federal, state or local laws, statutes, rules and regulations pertaining to employment; and (ii) any claims for wrongful discharge, breach of express or implied contract, fraud, misrepresentation or any claims relating to benefits, compensation
or equity, or any other claims under any statute, rule or regulation or under the common law, including compensatory damages, punitive damages, attorney’s fees, costs, expenses and all claims for any other type of damage or relief. 

3.    The Released Claims shall not include: (i) any vested benefits which I hold under any Aramark pension or
welfare benefit plan; (ii) any claims to enforce my contractual rights under, or with respect to, the Letter Agreement; (iii) any rights to workers’ compensation benefits or unemployment insurance as required by applicable law, or
(iv) any claims that arise after the date on which I execute this Second Release and Waiver of Claims. The Release and Waiver of Claims does not apply to any claim that cannot be released in this Agreement as a matter of law. In addition,
nothing herein prevents me from filing a charge or complaint with the Equal 

 
Employment Opportunity Commission (“EEOC”) or similar state or local agency or my ability to participate in any investigation or proceeding conducted by the EEOC or such similar state
or local agency; provided however, that pursuant to Paragraphs 1 and 2 of this Second Release and Waiver of Claims, I am waiving, to the fullest extent permitted by law, any right to recover monetary damages or any other form of personal relief in
connection with any such charge, investigation or proceeding. To the extent I receive any personal or monetary relief in connection with any such charge, investigation or proceeding, Aramark will be entitled to an offset for the payments made
pursuant to Paragraph 2 of the foregoing letter agreement. 
 Nothing in the Letter Agreement or this Second Release and Waiver of Claims shall prohibit or
restrict me or my attorneys from lawfully, and without notice to Aramark: (a) initiating communications directly with, cooperating with, providing information to, causing information to be provided to, or otherwise assisting in an investigation
by any governmental or regulatory agency, entity, or official(s) (collectively, “Governmental Authorities”) regarding a possible violation of any law; (b) responding to any inquiry or legal process directed to me individually (and not
directed to Aramark and/or its subsidiaries) from any such Governmental Authorities; (b) testifying, participating or otherwise assisting in an action or proceeding by any such Governmental Authorities relating to a possible violation of law;
or (d) making any other disclosures that are protected under the whistleblower provisions of any applicable law. Additionally, pursuant to the federal Defend Trade Secrets Act of 2016, I shall not be held criminally or civilly liable under any
federal or state trade secret law for the disclosure of a trade secret that: (a) is made (i) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the
purpose of reporting or investigating a suspected violation of law; or (b) is made to my attorney in relation to a lawsuit for retaliation against me for reporting a suspected violation of law; or (c) is made in a complaint or other
document filed in a lawsuit or other proceeding, if such filing is made under seal. Nor does the Letter Agreement or this Second Release and Waiver of Claims require me to obtain prior authorization from Aramark before engaging in any conduct
described in this Paragraph, or to notify Aramark that I have engaged in any such conduct. 
 4.    I expressly
understand and agree that the obligations of Aramark as set forth in the Letter Agreement are in lieu of any and all other amounts which I might be, am now, or may become, entitled to receive from Aramark upon any claim released herein. I also
expressly understand and agree that the Separation Payments paid to me under the Letter Agreement are in addition to what I would otherwise be entitled to receive following the end of my employment. Other than as provided in the Letter Agreement, I
acknowledge and agree that I have received all entitlements due from Aramark relating to my employment with Aramark including, but not limited to, all wages earned, bonuses, sick pay, vacation pay and any other paid and unpaid leave for which I was
eligible and to which I was entitled, and that no other entitlements are due to me other than as set forth in the Letter Agreement. 

5.    I acknowledge that the Older Workers Benefit Protection Act (“OWBPA”) requires Aramark to provide me with
the following disclosures to ensure my release and waiver of claims under the federal Age Discrimination in Employment Act is knowing and voluntary and I acknowledge and agree as follows: 

 

	 	a.	 I have read carefully and fully understand the terms of this Second Release and Waiver of Claims and that
Aramark advises me by the Letter Agreement to consult with an attorney and further I have had the opportunity to consult with an attorney prior to signing this Second Release and Waiver of Claims. 

  
 2 

	 	b.	 I fully understand the Second Release and Waiver of Claims that I am signing. 

 

	 	c.	 I am signing this Second Release and Waiver of Claims voluntarily and knowingly and I have not relied on any
representations, promises or agreements of any kind made to me in connection with my decision to accept the terms of this Second Release and Waiver of Claims, other than those set forth in this Second Release and Waiver of Claims and the Letter
Agreement. 

  

	 	d.	 I have been given at least twenty-one (21) days to consider
whether I want to sign this Second Release and Waiver of Claims. To the extent I have executed this Second Release and Waiver of Claims within less than twenty-one (21) days after its delivery to me, my
decision to execute this Second Release and Waiver of Claims prior to the expiration of such twenty-one (21) day period was entirely voluntary. 

 

	 	e.	 Any changes to the Letter Agreement or this Second Release and Waiver of Claims made by Aramark, whether
material or immaterial, do not restart the running of the twenty-one (21) day consideration period. 

  

	 	f.	 I have the right to revoke this Second Release and Waiver of Claims within seven (7) days after it is
signed by me. I further acknowledge that I will not receive any payments or benefits due to me under the Letter Agreement before the seven (7) day revocation period (the “Revocation Period”) has passed and then only if I have not
revoked this Second Release and Waiver of Claims. 

 This Second Release and Waiver of Claims shall take effect on the first business day
following the expiration of the Revocation Period, provided this Second Release and Waiver of Claims has not been revoked by me as provided above during such Revocation Period. Intending to be legally bound, I hereby execute this Second Release and
Waiver of Claims. 
  

	
	  

	Keith Bethel

 DATED: December     , 2020 

  
 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00313-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00313-of-00352.parquet"}]]